-+ 0.00%
-+ 0.00%
-+ 0.00%
Nipro wins FDA 510(k) clearance for ELISIO-HX dialyzer in US
Share
Listen to the news
Nipro wins FDA 510(k) clearance for ELISIO-HX dialyzer in US
  • Nipro won FDA 510(k) clearance for its ELISIO-HX dialyzer, effective July 28, 2026.
  • Clearance enables U.S. commercialization of the medium-cutoff dialyzer, supporting the rollout of its HDs expanded hemodialysis approach.
  • Nipro plans to begin U.S. commercialization immediately.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nipro Corporation published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending